Menopause-Cardiology Consensus Statement On Cardiovascular Disease And On HRT

A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT. The International Menopause Society consensus statement was developed at a Workshop** between menopause specialists and cardiologists. The Task Force on Gender of the European Society of Cardiology participated in the Workshop.

source : www.medicalnewstoday.com

Related News:

• Alkermes Unveils Long-Acting Injectable Proprietary Platform For Treatment Of Schizophrenia And Other CNS Disorders
• Kidney Cancer Drug Shows Promising Results
• Launch Of Ipsen’s Decapeptyl(R) 6-Month Formulation (LP 22.5 Mg) In France For The Treatment Of Prostate Cancer
• Clinic Closure Leaves Indigent Dialysis Patients Looking For Treatment
• Launch Of Ipsen’s Decapeptyl 6-Month Formulation (LP 22.5 Mg) In France For The Treatment Of Advanced Or Metastatic Hormone-Dependent Prostate Cancer
• Household Pesticides Contaminate Storm Runoff And Sewage Treatment Outflow
• Recordati : Silodosin Approved By The European Commission For The Treatment Of The Signs And Symptoms Of Benign Prostatic Hyperplasia
• Auxilium Announces U.S. Food And Drug Administration Approval For XIAFLEXTM For The Treatment Of Dupuytren’s Contracture
• Two Studies Find Artefill(R) To Be A Long-Term Treatment Option For Facial Lipoatrophy
• New Treatment For Chronic Pain Condition

Details :
Submited at Wednesday, November 25th, 2009 at 1:00 pm on Endocrinology by madison
Comment RSS 2.0 - leave a comment - trackback